Literature DB >> 23370738

Etiology and factors contributing to the severity and mortality of community-acquired pneumonia.

Takashi Ishiguro1, Noboru Takayanagi, Shozaburo Yamaguchi, Hideaki Yamakawa, Keitaro Nakamoto, Yotaro Takaku, Yosuke Miyahara, Naho Kagiyama, Kazuyoshi Kurashima, Tsutomu Yanagisawa, Yutaka Sugita.   

Abstract

OBJECTIVE: Community-acquired pneumonia (CAP) remains a major cause of death. No studies have reported the use of rapid influenza diagnostic tests (RIDT) for the etiological diagnosis, and the factors contributing to severity and mortality have not yet been fully investigated. The aim of this study was to review the etiologies of CAP using RIDT and to identify risk factors related to the severity and mortality of the disease.
METHODS: This retrospective study assessed these factors in hospitalized patients, with special emphasis on microbial etiology.
RESULTS: A total of 1,032 patients aged 63.9±18.3 years were studied, 66.2% of whom were men. Microbial identification was obtained in 57.0% of the cases. The most frequent causative microbial agents were Streptococcus pneumoniae, Mycoplasma pneumoniae and the influenza virus, and the second most frequent pathogens in the patients with severe CAP and the non-survivors were S. pneumoniae and the influenza virus. Age (≥65 years), chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, dementia and Legionella spp. infection and polymicrobial infection were each found to be independent factors related to severity in the multivariate analysis, whereas "unidentified pathogen" was found to be an independent factor for non-severe CAP. Age (≥65 years), chronic pulmonary aspergillosis, post-lung cancer surgery and severe CAP were found to be independent factors for non-survival according to a multivariate analysis.
CONCLUSION: In addition to S. pneumoniae, the influenza virus was a frequent cause of CAP overall and a frequent causative pathogen in both severe cases of CAP and non-survivors. Legionella spp. infection and polymicrobial infection were found to be an independent factor for the severity of CAP along with advanced age and certain comorbidities. An advanced age, certain respiratory comorbidities and severe CAP were found to be important independent factors for the mortality of CAP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370738     DOI: 10.2169/internalmedicine.52.8830

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  38 in total

1.  Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.

Authors:  Hana Čipčić Paljetak; Donatella Verbanac; Jasna Padovan; Miroslava Dominis-Kramarić; Željko Kelnerić; Mihaela Perić; Mihailo Banjanac; Gabrijela Ergović; Nerrisa Simon; John Broskey; David J Holmes; Vesna Eraković Haber
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 2.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.

Authors:  J Pradelli; K Risso; F G de Salvador; E Cua; R Ruimy; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-02       Impact factor: 3.267

4.  Community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Authors:  Aykut Cilli
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

5.  Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells.

Authors:  Jeanette Gaydos; Alicia McNally; Ruixin Guo; R William Vandivier; Philip L Simonian; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

6.  Effect of CARD9 Deficiency on Neutrophil-Mediated Host Defense against Pulmonary Infection with Streptococcus pneumoniae.

Authors:  Shigenari Ishizuka; Rin Yokoyama; Ko Sato; Ryuhei Shiroma; Ayako Nakahira; Hideki Yamamoto; Kazuki Takano; Takafumi Kagesawa; Tomomitsu Miyasaka; Jun Kasamatsu; Emi Kanno; Hiromasa Tanno; Keiko Ishii; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

7.  Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data.

Authors:  Koichi Kobayashi; Taisuke Jo; Wataru Mimura; Maho Suzukawa; Nobuharu Ohshima; Goh Tanaka; Manabu Akazawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Takahide Nagase; Hideaki Nagai
Journal:  Hum Vaccin Immunother       Date:  2021-04-20       Impact factor: 3.452

8.  Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.

Authors:  Thomas M File; Elizabeth Alexander; Lisa Goldberg; Anita F Das; Christian Sandrock; Susanne Paukner; Gregory J Moran
Journal:  BMC Pulm Med       Date:  2021-05-08       Impact factor: 3.317

9.  Influenza vaccination and healthcare workers: barriers and predisposing factors.

Authors:  Assunta Guillari; Francesco Polito; Gianluca Pucciarelli; Nicola Serra; Gianpaolo Gargiulo; Maria Rosaria Esposito; Stefano Botti; Teresa Rea; Silvio Simeone
Journal:  Acta Biomed       Date:  2021-03-25

Review 10.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  L Hogerwerf; B DE Gier; B Baan; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2017-09-26       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.